New drug for high triglycerides in diabetic kidney disease
Part of Hormones & metabolism clinical trials.
This study tests a new drug (DR10624) to see if it helps lower high blood fats (triglycerides) and improve kidney health in people who have both type 2 diabetes and diabetic kidney disease. If you qualify, you may receive the study drug as part of the trial.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- Your body mass index (BMI) is between 19 and 45, and your weight is at least 50 kg (about 110 lbs).
- Your triglycerides (a type of fat in your blood) are moderately high — between 2.3 and 5.7 mmol/L — on at least two tests taken more than a week apart.
- You have type 2 diabetes and have been taking the same diabetes medicines for at least 8 weeks.
- You have diabetic kidney disease (kidney damage caused by diabetes) and are on a stable kidney-protective medicine for at least 4 weeks.
- You do not have significant heart, pancreas, or other serious health problems that could make the trial unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational medication called DR10624 for people with very high triglycerides, a type of fat in the blood that can increase the risk of heart problems and pancreatitis. The trial aims to see if this drug can safely lower triglycerides better than standard care.
This trial tests a new drug, DR10624, to see if it can lower high triglycerides and reduce plaque in the carotid artery (the main artery in your neck). It may help people with both conditions who are also overweight.
This study tests a new medicine called DR10624 to see if it can lower very high levels of triglycerides (a type of fat in the blood) in people who have not been helped enough by standard treatments. The study compares the new drug to a placebo (a dummy shot) over several months.
This study tests a new medicine called AP303 for people with type 2 diabetes and chronic kidney disease. The goal is to see if it is safe and how the body processes it. If you have diabetes and your kidneys are not working as well as they used to, this trial might help find new treatment options.
This study looks at how a new injection (HDM1005) is processed by the body in people with different levels of kidney function, including healthy volunteers. It aims to help understand dosing for people with kidney issues.
This trial tests a new oral medication (DWP16001) for people with type 2 diabetes who also have moderate kidney problems. It aims to see if the drug is safe and helps control blood sugar while protecting kidney function.
Hear when a new Hypertriglyceridemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.